Exhibit 107

FORM S-1/A

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

(Form Type)

QUOIN PHARMACEUTICALS LTD.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

Security Type

Security Class Title(1)

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price(2)

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial Effective Date

Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward

Newly Registered Securities

Fees to be paid

Equity

Ordinary shares, no par value per share (“Ordinary Shares”), represented by American Depositary Shares (“ADSs”)(3)

Rule 457(o)

$20,000,000.00

0.00011020

$2,204.00(4)

Other

Pre-Funded Warrants to purchase Ordinary Shares represented by ADSs

Other

Other

Common Warrants to purchase Ordinary Shares represented by ADSs

Other

	Equity	Ordinary Shares represented by ADSs issuable upon the exercise of Pre-Funded Warrants	Other
	Equity	Ordinary Shares represented by ADSs issuable upon the exercise of Common Warrants	Other
Fees Previously Paid					—
Carry Forward Securities
Carry Forward Securities
Total Offering Amounts				$20,000,000.00	$2,204.00
Total Fees Previously Paid					$1,102.00
Total Fee Offsets					$0.00
Net Fee Due					$1,102.00

(1) Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), there are also being registered such additional securities that may be issued because of events such as recapitalizations, stock dividends, stock splits and reverse stock splits, and similar transactions.

(2) Estimated solely for the purpose of determining the amount of the registration fee in accordance with Rule 457(o) under the Securities Act.

(3) American Depositary Shares (“ADSs”) issuable upon deposit of ordinary shares registered hereby have been registered under a separate registration statement on Form F-6 (Registration No. 333-212698) filed with the Securities and Exchange Commission. Each ADS represents five thousand (5,000) ordinary shares (“Ordinary Shares”). The proposed maximum aggregate offering price of the Ordinary Shares represented by ADSs proposed to be sold in the offering will be reduced on a dollar-for-dollar basis based on the aggregate offering price of the Pre-Funded Warrants offered and sold in the offering (plus the aggregate exercise price of the Ordinary Shares represented by ADSs issuable upon exercise of the Pre-funded Warrants), and as such the proposed aggregate maximum offering price of the Ordinary Shares represented by ADSs and Pre-Funded Warrants (including Ordinary Shares represented by ADSs issuable upon exercise of the Pre-funded Warrants), if any, is $20,000,000.

(4) Calculated pursuant to Rule 457(o) under the Securities Act based on an estimate of the proposed maximum aggregate offering price.